Immunex Message Board - Msg: 14068966

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Michael Yang who started this subject	7/18/2000 10:23:35 PM
From: medicineman1	Read Replies (2) of 656

I own a pharmacy. Enbrel is gaining momentum. It will be interesting to see the effect that Remicade has on future sales. Regardless of competitor activity, Immunex has such innovative approaches, that I can't wait to see what their asthma product will be capable of.....I realize that the asthma drug is still far from being approved, and availability may be way down the road (if ever), but if it is similar to Enbrel....(as far as it being a new, innovative therapy or delivery system), this stock will experience another major increase in shareholder value.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next